Form D · Other Technology

SYNTHETIC GENOMICS INC

La Jolla, CA · CIK 0001341812

Offering snapshot reported Feb 5, 2013 · SEC filing

Reported sold
$10M
Offering amount: $100M
Investors reported
1
Form D · investor count
Minimum accepted
$11
Reported outside-investor minimum
First sale
Jan 29, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 5, 2013Initial$10,000,001No comparison1SEC filing
Jan 4, 2011Amendment$35,000,000$25,000,000vs Jun 3, 20106SEC filing
Jun 3, 2010Initial$10,000,000No comparison1SEC filing
Oct 13, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-191354

Source: Form D, filed Feb 5, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Juan Enriquez Director
Jim Flatt Executive
Alfonso Romo Garza Director
Steve Jurvetson Director
David Kiernan Director
Gregory T. Lucier Director
Greg Lucier Director
Joseph Mahler Executive
Walter J. Mc Bride Executive
Joel Mc Comb Executive
Aristides Patrinos Executive
Alfonso Romo Director
Barry Schuler Director
Hamilton Smith Director, Executive
Tan Sri Lim Kok Thay Director
J. Craig Venter Director, Executive
J. Craig Venter Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
11149 North Torrey Pines Road
La Jolla, CA, 92037